Skip to main content
Erschienen in: BMC Infectious Diseases 1/2020

Open Access 01.12.2020 | Research article

Presence of urinary symptoms in bacteremic urinary tract infection: a retrospective cohort study of Escherichia coli bacteremia

verfasst von: Anthony D. Bai, Michael J. Bonares, Samuel Thrall, Chaim M. Bell, Andrew M. Morris

Erschienen in: BMC Infectious Diseases | Ausgabe 1/2020

Abstract

Background

It is important to understand clinical features of bacteremic urinary tract infection (bUTI), because bUTI is a serious infection that requires prompt diagnosis and antibiotic therapy. Escherichia coli is the most common and important uropathogen. The objective of our study was to characterize the clinical presentation of E coli bUTI.

Methods

Retrospective cohort study of consecutive adult patients admitted for community acquired E. coli bacteremia from January 1, 2015 to December 31, 2016 was conducted at 4 acute care academic and community hospitals in Toronto, Ontario, Canada. Logistic regression models were developed to identify E coli bUTI cases without urinary symptoms.

Results

Of 462 patients with E. coli bacteremia, 284 (61.5%) patients had a urinary source. Of these 284 patients, 161 (56.7%) had urinary symptoms. In a multivariable model, bUTI without urinary symptoms were associated with older age (age < 65 years as reference, age 65–74 years had OR of 2.13 95% CI 0.99–4.59 p = 0.0523; age 75–84 years had OR of 1.80 95% CI 0.91–3.57 p = 0.0914; age > =85 years had OR of 2.95 95% CI 1.44–6.18 p = 0.0036) and delirium (OR of 2.12 95% CI 1.13–4.03 p = 0.0207). Sepsis by SIRS criteria was present in 274 (96.5%) of all bUTI cases and 119 (96.8%) of bUTI cases without urinary symptoms.

Conclusion

The majority of patients with E. coli bacteremia had a urinary source. A significant proportion of bUTI cases had no urinary symptoms elicited on history. Elderly and delirious patients were more likely to have bUTI without urinary symptoms. In elderly and delirious patients with sepsis by SIRS criteria but without a clear infectious source, clinicians should suspect, investigate, and treat for bUTI.

Background

Expert consensus and stewardship interventions emphasize treatment of bacteriuria based on urinary symptoms [14]. However, clinicians often diagnose and treat elderly patients for urinary tract infection (UTI) when they have only non-specific symptoms such as delirium based on the belief that elderly patients with UTI may present without localizing symptoms [57]. This raises uncertainty as to what constitutes symptoms of UTI, what is asymptomatic bacteriuria, and whether it warrants treatment. Hereafter, we use the term asymptomatic bacteriuria to signify bacteriuria without any urinary symptoms.
Bacteriuria with bacteremia is a true infection requiring treatment, so it can be used to guide diagnostic criteria for UTI. Diagnostic criteria for UTI should capture all bacteremic UTI (bUTI), because it is associated with a higher mortality rate [8, 9]. Prior studies suggested that elderly patients with bUTI often do not have urinary symptoms [1012], which is recognized by Centre of Disease Control as “asymptomatic bacteremic urinary tract infection” [13]. However, prior studies do not provide alternative clinical features to reliably capture bUTI [1012].
Approximately 20–30% of patients presenting to emergency department with febrile or complicated UTI or pyelonephritis have bacteremia [1416]. Escherichia coli is the most important pathogen for UTI and accounts for over 70% of all cases [17, 18]. In patients admitted to hospital with E coli bacteriuria who had a blood culture done, approximately 15% of patients had E coli bacteremia [19].
We conducted a study on E. coli bUTI patients to characterize the proportion of and risk factors for bUTI without urinary symptoms. We also aimed to find clinical features that would be sensitive enough to capture bUTI cases without urinary symptoms.

Methods

Study design

We conducted a retrospective cohort study at 4 acute care academic and community hospitals in the Greater Toronto Area. Research ethics board approval was obtained from each institution.
The study included consecutive adult patients admitted to the hospital for community acquired E. coli bacteremia from January 1, 2015 to December 31, 2016. Community acquired bacteremia was defined by positive blood culture collected at admission or within 48 h of hospital admission. E. coli bacteremia was defined as at least 1 positive blood culture for E. coli. Patients were excluded if they had an unclear infectious focus. This group was likely composed of patients with urinary source as well as patients with non-urinary source. Analysis and comparison to this mixed patient population would be difficult to interpret.

Data collection

Data were obtained from electronic and paper medical records at each hospital site and entered into a standardized case report form. Data on demographics, comorbidities, clinical presentation, investigations, microbiological data, investigations, surgical interventions, antibiotic therapy and clinical outcomes were collected. A second auditor performed sample reliability checks on 10% of the population.

Variable definitions

Comorbidities were entered as per Charlson comorbidity index [20].
Urinary source (i.e. bUTI) required a urine culture with significant monomicrobial growth of E. coli > =10 × 10^6 CFU/L and any of the following criteria:
1)
Clinical urinary tract infection as per diagnostic criteria for treatment by Loeb et al. [21]. Patients were diagnosed with UTI based on dysuria or > =2 of the following: fever, urgency, flank pain, urinary incontinence, shaking chills, frequency, gross hematuria or suprapubic pain [21]. Patients with urinary catheter were diagnosed with UTI based on > = 1 of the following: new costovertebral tenderness, rigors, new onset delirium or fever [21].
 
2)
Imaging findings suggestive of pyelonephritis including perinephric stranding or hydronephrosis with flank pain or costovertebral angle (CVA) tenderness
 
3)
Recent urologic procedure (including ureteric stenting, cystoscopy, prostate biopsy) with no other clear source
 
4)
Monomicrobial growth of E. coli in blood and urine culture with the same susceptibility pattern and no other obvious source on clinical assessment
 
Biliary source was defined as any of the following:
1)
Evidence of cholecystitis, choledocholithiasis, or cholangitis on imaging
 
2)
Known cholecystostomy tube or biliary malignancy with no other obvious source
 
3)
Recent manipulation of biliary tree including ERCP with no other obvious source
 
Intra-abdominal source was defined as any of the following:
1)
Evidence of intra-abdominal abscess, appendicitis, diverticulitis, pancreatitis or mass on abdominal imaging
 
2)
Known intra-abdominal drain with no other obvious source
 
3)
Recent intra-abdominal surgery with no other obvious source
 
The above criteria were also checked for agreement with the main responsible physician’s diagnosis for accuracy. Other infectious foci including pneumonia were based on the clinician’s final diagnosis.
Urinary symptoms and signs were based on the clinician’s documentation on presentation. Urinary symptoms included dysuria, urinary urgency, urinary frequency, gross hematuria, flank pain, suprapubic pain and urinary retention. Urinary signs included suprapubic tenderness and costovertebral or flank tenderness. Hereafter, bUTI without urinary symptoms refer to bUTI without any of the aforementioned urinary symptoms or signs.
Patients were screened regularly by nurses and assessed by physicians for delirium based on the Confusion Assessment Method (CAM) criteria [22]. Fever was defined as > 37.8C in elderly patients age > 65 [23] and > =38C in all other patients. Sepsis as per the SIRS [24] and qSOFA [25] score were calculated for all patients.
Urinalysis was done using urine test strips.
History of prior UTI was based on patient reporting, as documented in the patient chart by the main responsible physician.

Outcomes

Patients were followed until death in hospital or discharge. Length of stay was calculated from time of blood culture collection to discharge or death in hospital.

Statistical analysis

Comparisons between two groups were done with Wilcoxon rank-sum test for non-normally distributed continuous variables and Fisher’s exact test for categorical variables.
Diagnostic properties were determined for clinical factors as the test and urinary source as criterion standard. For example, if dysuria was the test, then a true positive was a patient who had dysuria and bUTI. A true negative was a patient who did not have dysuria and had a non-urinary source for the E. coli bacteremia. A false positive was a patient who had dysuria and a non-urinary source for the E. coli bacteremia. A false negative was a patient who did not have dysuria, but had bUTI. We calculated sensitivity and specificity with 95% confidence intervals (CI) using the Wilson method. For likelihood ratios, we calculated the 95% CI according to the method described by Simel et al. [26].
In patients with bUTI, a univariate logistic regression model was done predicting bUTI without urinary symptoms. Potential predictors were selected a priori, which included age, gender, stroke, dementia, urinary risk factors, delirium, and severity of infection. Significant predictors were selected based on p < 0.2 from univariate analyses. A final multivariable logistic regression model of significant predictors was selected based on clinical judgment, p-value, full model with all predictors, as well as both forward and backward stepwise regression based on Akaike information criterion. Hospital site was forced as a predictor into this model.
There are < 5% missing data for all variables, so listwise deletion was done for analyses such as modeling.
All reported CI were 2-sided 95% intervals and all tests were 2-sided with a P < 0.05 significance level. All analyses were done with R version 3.6.3 (R Foundation for Statistical Computing, Vienna, Austria).

Results

In total, 462 patients with E. coli bacteremia and a known infectious source were included in the analysis (Fig. 1). Of the 462 patients, 284 (61.5%) patients had a bUTI and 178 (38.5%) patients had a non-urinary source (Table 1). Baseline characteristics of patients with E coli bacteremia and an unclear source are described in Additional file 1: Table S1.
Table 1
Baseline characteristics of E. coli bacteremic patients with bUTI versus non-urinary source
 
Patients with bUTI (N = 284)
Patients with non-urinary source (N = 178)
p-value
Demographics
 Age categories
  
0.3666
   < 65 years
85 (29.9%)
41 (23.0%)
 
  65–74 years
48 (16.9%)
34 (19.1%)
 
  75–84 years
80 (28.2%)
50 (28.1%)
 
   > =85 years
71 (25.0%)
53 (29.8%)
 
 Age median (IQR)
76.0 (62.0–84.7)
77.9 (66.7–86.0)
0.0408
 Female
207 (72.9%)
86 (48.3%)
< 0.0001
 Long term care home
44 (15.5%)
16 (9.0%)
0.0469
Admitting service
  
0.0018
 Medicine
264 (93.0%)
147 (82.6%)
 
 Surgery
18 (6.3%)
27 (15.2%)
 
 ICU
2 (0.7%)
4 (2.3%)
 
Charlson comorbidity score
  
0.0875
 0
181 (63.7%)
96 (53.9%)
 
 1
39 (13.7%)
27 (15.2%)
 
  > =2
64 (22.5%)
55 (30.9%)
 
Charlson comorbidity
 Stroke
21 (7.4%)
8 (4.5%)
0.2416
 Dementia
17 (6.0%)
10 (5.6%)
> 0.9999
 Diabetes
22 (7.8%)
21 (11.8%)
0.1874
 Diabetes with complications
16 (5.6%)
15 (8.4%)
0.2562
Source of infection
 Urinary
284 (0%)
0 (0%)
 
 Abdomen
0 (0%)
109 (61.2%)
 
 Biliary
0 (0%)
60 (33.7%)
 
 Pneumonia
0 (0%)
9 (5.1%)
 
History of urinary risk factors
 Chronic indwelling Foley catheter
12 (4.2%)
4 (2.3%)
0.3059
 Benign prostate hypertrophy
16 (5.6%)
17 (9.6%)
0.1373
 Urinary malignancy
13 (4.6%)
6 (3.4%)
0.6341
 Prior urinary tract infection
65 (22.9%)
15 (8.4%)
< 0.0001
 Nephrolithiasis
16 (5.6%)
14 (7.9%)
0.3405
 Cystoscopy
8 (2.8%)
0 (0%)
0.0259
 Prostate biopsy
6 (2.1%)
0 (0%)
0.0875
 Other urologic procedure
37 (13.0%)
13 (7.3%)
0.0645
Urinary symptoms
 Dysuria
63 (22.2%)
13 (7.3%)
< 0.0001
 Urinary urgency
19 (6.7%)
5 (2.8%)
0.0845
 Urinary frequency
61 (21.5%)
5 (2.8%)
< 0.0001
 Gross hematuria
14 (4.9%)
2 (1.1%)
0.0351
 Flank pain
52 (18.3%)
11 (6.2%)
0.0001
 Suprapubic abdominal pain
43 (15.1%)
8 (4.5%)
0.0004
 Urinary retention
11 (3.9%)
5 (2.8%)
0.6112
Urinary signs
 Suprapubic tenderness
20 (7.0%)
8 (4.5%)
0.3193
 CVA tenderness
28 (9.9%)
6 (3.4%)
0.0098
Any urinary symptoms or signs
161 (56.7%)
41 (23.0%)
< 0.0001
Urinalysis
 Proteinuria
203 / 249 (81.5%)
99 / 139 (71.2%)
0.0220
 Hematuria
221 / 249 (88.8%)
101 / 139 (72.7%)
0.0001
 Leukocytes
223 / 249 (89.6%)
73 / 139 (52.5%)
< 0.0001
 Nitrite
121 / 249 (48.6%)
40 / 139 (28.8%)
0.0002
 Leukocytes or nitrites
230 / 249 (92.4%)
79 / 139 (56.8%)
< 0.0001
Severity of Infection
 Delirium
68 (23.9%)
38 (21.4%)
0.5703
 Fever
209 (73.6%)
127 (71.4%)
0.5937
 Sepsis by SIRS criteria
274 (96.5%)
171 (96.1%)
0.8050
 Sepsis by qSOFA criteria
110 (38.7%)
88 (49.4%)
0.0264
 Hypotensive shock SBP < 90
223 (78.5%)
136 (76.4%)
0.6462
 Transfer to ICU in 72 h
19 (6.7%)
21 (11.8%)
0.0630
Outcome
 Death in hospital
17 (6.0%)
12 (6.7%)
0.8442
Urinary frequency had the highest positive likelihood ratio (PLR) of 7.6 (95% CI 3.1–18.7) for ruling in urinary source (Table 2). Other urinary symptoms and signs have PLR ranging from 1.4 to 4.4 and negative likelihood ratio (NLR) ranging from 0.81 to 0.99. On clinical assessment, no urinary symptoms and signs had a NLR of 0.56 (95% CI 0.48–0.66). Negative leukocytes and nitrites on urinalysis had the lowest NLR of 0.18 (95% CI 0.11–0.28) for ruling out a urinary source.
Table 2
Diagnostic utility of symptoms and signs for bacteremic UTI
 
Sensitivity
% (95% CI)
Specificity
% (95% CI)
PLR
(95% CI)
NLR
(95% CI)
Urinary symptoms
 Dysuria
22 (18–27)
93 (88–96)
3.0 (1.7–5.4)
0.84 (0.78–0.90)
 Urinary urgency
7 (4–10)
97 (94–99)
2.4 (0.9–6.3)
0.96 (0.92–1.00)
 Urinary frequency
22 (17–27)
97 (94–99)
7.6 (3.1–18.7)
0.81 (0.76–0.86)
 Gross hematuria
5 (3–8)
99 (96–100)
4.4 (1.0–19.1)
0.96 (0.93–0.99)
 Flank pain
18 (14–23)
94 (89–97)
3.0 (1.6–5.5)
0.87 (0.81–0.93)
 Suprapubic abdominal pain
15 (11–20)
96 (91–98)
3.4 (1.6–7.0)
0.89 (0.83–0.94)
 Urinary retention
4 (2–7)
97 (94–99)
1.4 (0.5–3.9)
0.99 (0.96–1.02)
Urinary signs
 Suprapubic tenderness
7 (5–11)
96 (91–98)
1.6 (0.7–3.5)
0.97 (0.93–1.02)
 CVA tenderness
10 (7–14)
97 (93–98)
2.9 (1.2–6.9)
0.93 (0.89–0.98)
Any urinary symptoms or signs
57 (51–62)
77 (70–83)
2.5 (1.8–3.3)
0.56 (0.48–0.66)
Urinalysis
 Proteinuria
82 (76–86)
29 (22–37)
1.1 (1.0–1.3)
0.64 (0.44–0.93)
 Hematuria
89 (84–92)
27 (21–35)
1.2 (1.1–1.4)
0.41 (0.26–0.64)
 Leukocytes
90 (85–93)
48 (39–56)
1.7 (1.4–2.0)
0.22 (0.15–0.33)
 Nitrite
49 (43–55)
71 (63–78)
1.7 (1.3–2.3)
0.72 (0.62–0.85)
 Leukocytes or nitrites
92 (88–95)
43 (35–52)
1.6 (1.4–1.9)
0.18 (0.11–0.28)
Of the 284 patients with bUTI, 123 (43.3%) had no urinary symptoms (Table 3). Fever and/or urinary symptoms were present in 244 (85.9%) patients with bUTI. In the univariate analysis, potential significant predictors of bUTI without urinary symptoms included age, dementia, benign prostate hypertrophy, prior UTI, nephrolithiasis, delirium, sepsis by qSOFA criteria, and hypotensive shock (Additional file 1: Table S2). In the final multivariable model, significant predictors included only age, delirium and prior UTI (Table 4, Additional file 1: Table S3). With increasing age, the proportion of patients with delirium and bUTI without urinary symptoms also increased (Additional file 1: Table S4).
Table 3
Characteristics and outcomes of E. coli bUTI patients with and without urinary symptoms or signs
 
bUTI with urinary symptoms (N = 161)
bUTI without urinary symptoms (N = 123)
p-value
Demographics
 Age categories
  
0.0025
   < 65 years
61 (37.9%)
24 (19.5%)
 
  65–74 years
26 (16.2%)
22 (17.9%)
 
  75–84 years
44 (27.3%)
36 (29.3%)
 
   > =85 years
30 (18.6%)
41 (33.3%)
 
 Age median (IQR)
72.8 (56.0–81.9)
79.0 (67.5–86.6)
0.0002
 Female
122 (75.8%)
85 (69.1%)
0.2271
 Long term care home
16 (9.9%)
28 (22.8%)
0.0045
Admitting service
  
0.4445
 Medicine
147 (91.3%)
117 (95.1%)
 
 Surgery
12 (7.5%)
6 (4.9%)
 
 ICU
2 (1.2%)
0 (0%)
 
Charlson comorbidity score
  
0.1632
 0
96 (59.6%)
85 (69.1%)
 
 1
27 (16.8%)
12 (9.8%)
 
  > =2
38 (23.6%)
26 (21.1%)
 
Charlson comorbidity
 Stroke
10 (6.2%)
11 (8.9%)
0.4933
 Dementia
7 (4.4%)
10 (8.1%)
0.2121
 Diabetes
15 (9.3%)
7 (5.7%)
0.3706
 Diabetes with complications
13 (8.1%)
3 (2.4%)
0.0660
History of urinary risk factors
 Chronic indwelling Foley catheter
7 (5.7%)
5 (3.1%)
0.3745
 Benign prostate hypertrophy
5 (3.1%)
11 (8.9%)
0.0401
 Urinary malignancy
9 (5.6%)
4 (3.3%)
0.4041
 Prior urinary tract infection
42 (26.1%)
23 (18.7%)
0.1559
 Nephrolithiasis
14 (8.7%)
2 (1.6%)
0.0097
 Cystoscopy
6 (3.7%)
2 (1.6%)
0.4727
 Prostate biopsy
2 (1.2%)
4 (3.3%)
0.4083
 Other urologic procedure
24 (14.9%)
13 (10.6%)
0.3739
Severity of Infection
 Delirium
26 (16.2%)
42 (34.2%)
0.0007
 Sepsis by SIRS criteria
155 (96.3%)
119 (96.8%)
> 0.9999
 Sepsis by qSOFA criteria
53 (32.9%)
57 (46.3%)
0.0268
 Hypotensive shock SBP < 90
120 (74.5%)
103 (83.7%)
0.0797
 Transfer to ICU in 72 h
9 (5.6%)
10 (8.1%)
0.4746
Empiric antibiotics before blood culture collection
15 (9.3%)
9 (7.3%)
0.6683
Outcome
 Death in hospital
5 (3.1%)
12 (9.8%)
0.0234
Table 4
Multivariable logistic regression model predicting bUTI without urinary symptoms
Predictor
Odds Ratio (OR)
(95% CI)
p-value
Age categories
  < 65 years
Reference
 
 65–74 years
2.13 (0.99–4.59)
0.0523
 75–84 years
1.80 (0.91–3.57)
0.0914
  > =85 years
2.95 (1.44–6.18)
0.0036
Delirium
2.12 (1.13–4.03)
0.0207
Prior urinary tract infection
0.56 (0.29–1.04)
0.0699
Hospital site was also forced as a predictor into this model. The estimates for different sites are not shown in this table, but can be found in Additional file 1: Table S3

Discussion

This retrospective cohort study of patients with E. coli bacteremia showed that the majority of patients (61.5%) had a urinary source. A significant proportion of patients (43.3%) with bUTI did not have any urinary symptoms or signs elicited on history or physical exam especially in context of older age and delirium. Even the inclusion of fever and/or urinary symptoms would miss approximately 1 in 7 bUTIs. Sepsis by SIRS criteria was present in almost all of the bUTI cases without urinary symptoms.
We used a comparison group of non-urinary source E. coli bacteremia patients. The majority of these patients had intra-abdominal or hepato-biliary infection, similar to prior studies [27, 28]. Patients with a non-urinary source had similar outcomes including mortality compared to patients with urinary source. We believe this is an appropriate comparison group as it simulates a common scenario whereby a patient presents with sepsis or E. coli bacteremia of unknown source, and the clinician must evaluate and determine the source of infection.
Our finding of a significant proportion of bUTI presenting without urinary symptoms in elderly patients is consistent with prior studies on bUTI [11, 12] and non-bacteremic UTI [29]. Although our study found urinary frequency to be useful for ruling in UTI, it demonstrated little diagnostic utility in a systematic review of observational studies [29]. This may be due to the wide variation in the case definition of UTI that includes asymptomatic bacteriuria without true infection. The usefulness of urinalysis in ruling out UTI in our study was similarly found in prior studies with a reported high sensitivity [30] and negative predictive value [31].
There are several reasons why an elderly patient with delirium and a UTI may have no urinary symptoms. Frail adults may have atypical presentation of infections [6, 32]. Even if such patients experience UTI symptoms, they may not be able to describe or demonstrate them due to cognitive dysfunction [6]. While clinical evaluation for typical urinary symptoms and signs were not sensitive to capture all bUTI, sepsis by SIRS criteria came close. The qSOFA components such as altered mental status and tachypnea tend to be non-specific for infection in elderly patients [33, 34]. This may lead to overtreatment and missed diagnosis of delirium causes other than infection [8]. In our study, qSOFA was not sensitive for bUTI, being positive in only 38.7% of all bUTI patients and 46.3% of bUTI patients without urinary symptoms. In contrast, SIRS criteria have been shown previously to be sensitive in identifying bacteremia in all patients [35] including elderly patients in particular [33]. Therefore, physicians may continue to use SIRS criteria for decisions on when to draw blood cultures, especially in elderly patients.
This study has several strengths. It included a large population of 284 bUTI cases compared to prior studies that ranged from 61 to 191 patients [1012]. It was conducted across academic and community hospitals, which increases its generalizability. Also, by limiting inclusion to those patients with bacteremia, it allows characterization of UTI without urinary symptoms and largely eliminates the inclusion of asymptomatic bacteriuria without true infection.
Our study has limitations that merit discussion. First, there are the inherent limitations from a retrospective chart review. However, the data collection was rigorous and a second auditor had performed sample data checking to ensure completeness and quality. The clinical assessment of patients for urinary symptoms and signs were not standardized and may vary between clinicians. Almost all patients in our study had sepsis as per SIRS or qSOFA criteria, and had a blood culture drawn at presentation. Therefore, all patients should have undergone a systematic evaluation for possible infectious foci including UTI. As well, the non-standardized approach reflects real world settings. Second, there may be ascertainment bias. The study could only capture patients in whom blood cultures were drawn. Physicians may be more likely to order blood cultures for patients in whom the symptoms are non-specific or the infectious source is uncertain. The study also likely selected sicker patients with higher suspicion for bacteremia. This could lead to overestimation of the diagnostic properties but does not affect our most important findings: that UTI is the most common cause of E. coli bacteremia, and most elderly or delirious patients had bUTI without urinary symptoms. Third, our study captured bUTI by E. coli only, so it would be an extrapolation to all bUTI. Nonetheless, E coli is the most common and important pathogen responsible for approximately 70% of pyelonephritis [17]. Fourth, UTI presentation may be different and unique in patients with spinal cord injury or disease. Unfortunately, our study did not collect information on spinal cord injury or disease. It is likely that many of these patients would have been captured in the variable of chronic indwelling Foley catheter.
These findings offer insight in the clinical presentation of E coli bUTI. Urinary symptoms are useful to diagnose UTI. However, elderly and/or delirious patients may have a bUTI despite having no urinary symptoms or signs elicited on history or exam. For these cases, in addition to symptoms and signs, SIRS criteria and positive urinalysis without any other clear infectious source may be important clues to a bUTI that require antibiotic therapy. Our study should be interpreted with caution and not be extrapolated to E coli bacteriuria without bacteremia. This is outside the scope of our study. Thus, our study does not address which patients are at risk for bUTI. This should be explored in future studies.
Our study adds to the evidence that UTI without urinary symptoms is common and important in elderly and/or delirious patients. We hope that this study can contribute towards a meaningful update of the concept of UTI symptoms. Emphasis on urinary symptoms without consideration of other aspects of the patient’s presentation is potentially harmful and may miss bUTI. A more holistic approach would consider other clinical factors including age, delirium and sepsis by SIRS criteria. This approach may help increase the chance of antibiotics being given to those who truly need it.

Conclusions

Most of the patients with E. coli bacteremia had a urinary source. A significant proportion of bUTI cases had no urinary symptoms. Elderly and delirious patients were more likely to have bUTI without urinary symptoms. In these elderly and delirious patients who satisfied SIRS criteria but without a clear infectious source, clinicians should suspect, investigate, and treat for bUTI.

Acknowledgements

We are indebted to Sarwat Abbasi, Deborah Somanader and Sheetal Vajaria, who helped with extracting patient data into the database and organizing the data.
Research ethics board approval was obtained from Mount Sinai Hospital Research Ethics Board (reference number 16–0129-C) and University Health Network Research Ethics Board (reference number 16–5446). As a retrospective study that reports de-identified data, patients’ consent for participation was waived.
Not applicable.

Competing interests

The authors declare that they have no competing interests.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
1.
Zurück zum Zitat Loeb M, Bentley DW, Bradley S, Crossley K, Garibaldi R, Gantz N, et al. Development of minimum criteria for the initiation of antibiotics in residents of long-term–care facilities: results of a consensus conference. Infect Control Hosp Epidemiol. 2001;22:120–4.CrossRef Loeb M, Bentley DW, Bradley S, Crossley K, Garibaldi R, Gantz N, et al. Development of minimum criteria for the initiation of antibiotics in residents of long-term–care facilities: results of a consensus conference. Infect Control Hosp Epidemiol. 2001;22:120–4.CrossRef
2.
Zurück zum Zitat Nicolle LE, Gupta K, Bradley SF, Colgan R, DeMuri GP, Drekonja D, et al. Clinical practice guideline for the management of asymptomatic bacteriuria: 2019 update by the Infectious Diseases Society of America. Clin Infect Dis. 2019;68:e83–110.CrossRef Nicolle LE, Gupta K, Bradley SF, Colgan R, DeMuri GP, Drekonja D, et al. Clinical practice guideline for the management of asymptomatic bacteriuria: 2019 update by the Infectious Diseases Society of America. Clin Infect Dis. 2019;68:e83–110.CrossRef
3.
Zurück zum Zitat Daniel M, Keller S, Mozafarihashjin M, Pahwa A, Soong C. An implementation guide to reducing overtreatment of asymptomatic bacteriuria. JAMA Intern Med. 2018;178:271–6.CrossRef Daniel M, Keller S, Mozafarihashjin M, Pahwa A, Soong C. An implementation guide to reducing overtreatment of asymptomatic bacteriuria. JAMA Intern Med. 2018;178:271–6.CrossRef
4.
Zurück zum Zitat Leis JA, Rebick GW, Daneman N, Gold WL, Poutanen SM, Lo P, et al. Reducing antimicrobial therapy for asymptomatic bacteriuria among noncatheterized inpatients: a proof-of-concept study. Clin Infect Dis. 2014;58:980–3.CrossRef Leis JA, Rebick GW, Daneman N, Gold WL, Poutanen SM, Lo P, et al. Reducing antimicrobial therapy for asymptomatic bacteriuria among noncatheterized inpatients: a proof-of-concept study. Clin Infect Dis. 2014;58:980–3.CrossRef
5.
Zurück zum Zitat Petty LA, Vaughn VM, Flanders SA, Malani AN, Conlon A, Kaye KS, et al. Risk factors and outcomes associated with treatment of asymptomatic Bacteriuria in hospitalized patients. JAMA Intern Med. 2019;179:1519–27.CrossRef Petty LA, Vaughn VM, Flanders SA, Malani AN, Conlon A, Kaye KS, et al. Risk factors and outcomes associated with treatment of asymptomatic Bacteriuria in hospitalized patients. JAMA Intern Med. 2019;179:1519–27.CrossRef
6.
Zurück zum Zitat D’Agata ED, Loeb MB, Mitchell SL. Challenges in assessing nursing home residents with advanced dementia for suspected urinary tract infections. J Am Geriatr Soc. 2013;61:62–6.CrossRef D’Agata ED, Loeb MB, Mitchell SL. Challenges in assessing nursing home residents with advanced dementia for suspected urinary tract infections. J Am Geriatr Soc. 2013;61:62–6.CrossRef
7.
Zurück zum Zitat Juthani-Mehta M, Drickamer MA, Towle V, Zhang Y, Tinetti ME, Quagliarello VJ. Nursing home practitioner survey of diagnostic criteria for urinary tract infections. J Am Geriatr Soc. 2005;53:1986–90.CrossRef Juthani-Mehta M, Drickamer MA, Towle V, Zhang Y, Tinetti ME, Quagliarello VJ. Nursing home practitioner survey of diagnostic criteria for urinary tract infections. J Am Geriatr Soc. 2005;53:1986–90.CrossRef
8.
Zurück zum Zitat Finucane TE. “Urinary tract infection”—requiem for a heavyweight. J Am Geriatr Soc. 2017;65:1650–5.CrossRef Finucane TE. “Urinary tract infection”—requiem for a heavyweight. J Am Geriatr Soc. 2017;65:1650–5.CrossRef
9.
Zurück zum Zitat Woodford HJ, George J. Diagnosis and management of urinary tract infection in hospitalized older people. J Am Geriatr Soc. 2009;57:107–14.CrossRef Woodford HJ, George J. Diagnosis and management of urinary tract infection in hospitalized older people. J Am Geriatr Soc. 2009;57:107–14.CrossRef
10.
Zurück zum Zitat Tal S, Guller V, Levi S, Bardenstein R, Berger D, Gurevich I, et al. Profile and prognosis of febrile elderly patients with bacteremic urinary tract infection. J Inf Secur. 2005;50:296–305. Tal S, Guller V, Levi S, Bardenstein R, Berger D, Gurevich I, et al. Profile and prognosis of febrile elderly patients with bacteremic urinary tract infection. J Inf Secur. 2005;50:296–305.
11.
Zurück zum Zitat Woodford H, Graham C, Meda M, Miciuleviciene J. Bacteremic urinary tract infection in hospitalized older patients—are any currently available diagnostic criteria sensitive enough? J Am Geriatr Soc. 2011;59:567–8.CrossRef Woodford H, Graham C, Meda M, Miciuleviciene J. Bacteremic urinary tract infection in hospitalized older patients—are any currently available diagnostic criteria sensitive enough? J Am Geriatr Soc. 2011;59:567–8.CrossRef
12.
Zurück zum Zitat Barkham TM, Martin FC, Eykyn SJ. Delay in the diagnosis of bacteraemic urinary tract infection in elderly patients. Age Ageing. 1996;25:130–2.CrossRef Barkham TM, Martin FC, Eykyn SJ. Delay in the diagnosis of bacteraemic urinary tract infection in elderly patients. Age Ageing. 1996;25:130–2.CrossRef
14.
Zurück zum Zitat Van Nieuwkoop C, Hoppe BP, Bonten TN, van’t Wout JW, Aarts NJ, Mertens BJ, et al. Predicting the need for radiologic imaging in adults with febrile urinary tract infection. Clin Infect Dis. 2010;51:1266–72.CrossRef Van Nieuwkoop C, Hoppe BP, Bonten TN, van’t Wout JW, Aarts NJ, Mertens BJ, et al. Predicting the need for radiologic imaging in adults with febrile urinary tract infection. Clin Infect Dis. 2010;51:1266–72.CrossRef
15.
Zurück zum Zitat Chen Y, Nitzan O, Saliba W, Chazan B, Colodner R, Raz R. Are blood cultures necessary in the management of women with complicated pyelonephritis? J Inf Secur. 2006;53:235–40. Chen Y, Nitzan O, Saliba W, Chazan B, Colodner R, Raz R. Are blood cultures necessary in the management of women with complicated pyelonephritis? J Inf Secur. 2006;53:235–40.
16.
Zurück zum Zitat Spoorenberg V, Prins JM, Opmeer BC, de Reijke TM, Hulscher ME, Geerlings SE. The additional value of blood cultures in patients with complicated urinary tract infections. Clin Microbiol Infect. 2014;20:O476–9.CrossRef Spoorenberg V, Prins JM, Opmeer BC, de Reijke TM, Hulscher ME, Geerlings SE. The additional value of blood cultures in patients with complicated urinary tract infections. Clin Microbiol Infect. 2014;20:O476–9.CrossRef
17.
Zurück zum Zitat Czaja CA, Scholes D, Hooton TM, Stamm WE. Population-based epidemiologic analysis of acute pyelonephritis. Clin Infect Dis. 2007;45:273–80.CrossRef Czaja CA, Scholes D, Hooton TM, Stamm WE. Population-based epidemiologic analysis of acute pyelonephritis. Clin Infect Dis. 2007;45:273–80.CrossRef
18.
Zurück zum Zitat Echols RM, Tosiello RL, Haverstock DC, Tice AD. Demographic, clinical, and treatment parameters influencing the outcome of acute cystitis. Clin Infect Dis. 1999;29:113–9.CrossRef Echols RM, Tosiello RL, Haverstock DC, Tice AD. Demographic, clinical, and treatment parameters influencing the outcome of acute cystitis. Clin Infect Dis. 1999;29:113–9.CrossRef
19.
Zurück zum Zitat Marschall J, Zhang L, Foxman B, Warren DK, Henderson JP. Both host and pathogen factors predispose to Escherichia coli urinary-source bacteremia in hospitalized patients. Clin Infect Dis. 2012;54:1692–8.CrossRef Marschall J, Zhang L, Foxman B, Warren DK, Henderson JP. Both host and pathogen factors predispose to Escherichia coli urinary-source bacteremia in hospitalized patients. Clin Infect Dis. 2012;54:1692–8.CrossRef
20.
Zurück zum Zitat Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–83.CrossRef Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–83.CrossRef
21.
Zurück zum Zitat Loeb M, Brazil K, Lohfeld L, McGeer A, Simor A, Stevenson K, et al. Effect of a multifaceted intervention on number of antimicrobial prescriptions for suspected urinary tract infections in residents of nursing homes: cluster randomised controlled trial. BMJ. 2005;331:669.CrossRef Loeb M, Brazil K, Lohfeld L, McGeer A, Simor A, Stevenson K, et al. Effect of a multifaceted intervention on number of antimicrobial prescriptions for suspected urinary tract infections in residents of nursing homes: cluster randomised controlled trial. BMJ. 2005;331:669.CrossRef
22.
Zurück zum Zitat Inouye SK, van Dyck CH, Alessi CA, Balkin S, Siegal AP, Horwitz RI. Clarifying confusion: the confusion assessment method: a new method for detection of delirium. Ann Intern Med. 1990;113:941–8.CrossRef Inouye SK, van Dyck CH, Alessi CA, Balkin S, Siegal AP, Horwitz RI. Clarifying confusion: the confusion assessment method: a new method for detection of delirium. Ann Intern Med. 1990;113:941–8.CrossRef
23.
Zurück zum Zitat High KP, Bradley SF, Gravenstein S, Mehr DR, Quagliarello VJ, Richards C, et al. Clinical practice guideline for the evaluation of fever and infection in older adult residents of long-term care facilities: 2008 update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;48:149–71.CrossRef High KP, Bradley SF, Gravenstein S, Mehr DR, Quagliarello VJ, Richards C, et al. Clinical practice guideline for the evaluation of fever and infection in older adult residents of long-term care facilities: 2008 update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;48:149–71.CrossRef
24.
Zurück zum Zitat American College of Chest Physicians, Society of Critical Care Medicine Consensus Conference Committee. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med. 1992;20:864–74.CrossRef American College of Chest Physicians, Society of Critical Care Medicine Consensus Conference Committee. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med. 1992;20:864–74.CrossRef
25.
Zurück zum Zitat Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315:801–10.CrossRef Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315:801–10.CrossRef
26.
Zurück zum Zitat Simel DL, Samsa GP, Matchar DB. Likelihood ratios with confidence: sample size estimation for diagnostic test studies. J Clin Epidemiol. 1991;44:763–70.CrossRef Simel DL, Samsa GP, Matchar DB. Likelihood ratios with confidence: sample size estimation for diagnostic test studies. J Clin Epidemiol. 1991;44:763–70.CrossRef
27.
Zurück zum Zitat Harris PN, Tambyah PA, Lye DC, Mo Y, Lee TH, Yilmaz M, et al. Effect of piperacillin-tazobactam vs meropenem on 30-day mortality for patients with E coli or Klebsiella pneumonia bloodstream infection and ceftriaxone resistance: a randomized clinical trial. JAMA. 2018;320:984–94.CrossRef Harris PN, Tambyah PA, Lye DC, Mo Y, Lee TH, Yilmaz M, et al. Effect of piperacillin-tazobactam vs meropenem on 30-day mortality for patients with E coli or Klebsiella pneumonia bloodstream infection and ceftriaxone resistance: a randomized clinical trial. JAMA. 2018;320:984–94.CrossRef
28.
Zurück zum Zitat Peralta G, Sanchez MB, Garrido JC, De Benito I, Cano ME, Martínez-Martínez L, et al. Impact of antibiotic resistance and of adequate empirical antibiotic treatment in the prognosis of patients with Escherichia coli bacteraemia. J Antimicrob Chemother. 2007;60:855–63.CrossRef Peralta G, Sanchez MB, Garrido JC, De Benito I, Cano ME, Martínez-Martínez L, et al. Impact of antibiotic resistance and of adequate empirical antibiotic treatment in the prognosis of patients with Escherichia coli bacteraemia. J Antimicrob Chemother. 2007;60:855–63.CrossRef
29.
Zurück zum Zitat Gbinigie OA, Ordóñez-Mena JM, Fanshawe TR, Plüddemann A, Heneghan C. Diagnostic value of symptoms and signs for identifying urinary tract infection in older adult outpatients: systematic review and meta-analysis. J Inf Secur. 2018;77:379–90. Gbinigie OA, Ordóñez-Mena JM, Fanshawe TR, Plüddemann A, Heneghan C. Diagnostic value of symptoms and signs for identifying urinary tract infection in older adult outpatients: systematic review and meta-analysis. J Inf Secur. 2018;77:379–90.
30.
Zurück zum Zitat Shimoni Z, Glick J, Hermush V, Froom P. Sensitivity of the dipstick in detecting bacteremic urinary tract infections in elderly hospitalized patients. PLoS One. 2017;12:e0187381.CrossRef Shimoni Z, Glick J, Hermush V, Froom P. Sensitivity of the dipstick in detecting bacteremic urinary tract infections in elderly hospitalized patients. PLoS One. 2017;12:e0187381.CrossRef
31.
Zurück zum Zitat Juthani-Mehta M, Tinetti M, Perrelli E, Towle V, Quagliarello V. Role of dipstick testing in the evaluation of urinary tract infection in nursing home residents. Infect Control Hosp Epidemiol. 2007;28:889–91.CrossRef Juthani-Mehta M, Tinetti M, Perrelli E, Towle V, Quagliarello V. Role of dipstick testing in the evaluation of urinary tract infection in nursing home residents. Infect Control Hosp Epidemiol. 2007;28:889–91.CrossRef
32.
Zurück zum Zitat Resnick NM, Marcantonio ER. How should clinical care of the aged differ? Lancet. 1997;350:1157–8.CrossRef Resnick NM, Marcantonio ER. How should clinical care of the aged differ? Lancet. 1997;350:1157–8.CrossRef
33.
Zurück zum Zitat Chou HL, Han ST, Yeh CF, Tzeng IS, Hsieh TH, Wu CC, Kuan JT, Chen KF. Systemic inflammatory response syndrome is more associated with bacteremia in elderly patients with suspected sepsis in emergency departments. Medicine (Baltimore). 2016;95:e5634.CrossRef Chou HL, Han ST, Yeh CF, Tzeng IS, Hsieh TH, Wu CC, Kuan JT, Chen KF. Systemic inflammatory response syndrome is more associated with bacteremia in elderly patients with suspected sepsis in emergency departments. Medicine (Baltimore). 2016;95:e5634.CrossRef
34.
Zurück zum Zitat Pfitzenmeyer P, Decrey H, Auckenthaler R, Michel JP. Predicting bacteremia in older patients. J Am Geriatr Soc. 1995;43:230–5.CrossRef Pfitzenmeyer P, Decrey H, Auckenthaler R, Michel JP. Predicting bacteremia in older patients. J Am Geriatr Soc. 1995;43:230–5.CrossRef
35.
Zurück zum Zitat Coburn B, Morris AM, Tomlinson G, Detsky AS. Does this adult patient with suspected bacteremia require blood cultures? JAMA. 2012;308:502–11.CrossRef Coburn B, Morris AM, Tomlinson G, Detsky AS. Does this adult patient with suspected bacteremia require blood cultures? JAMA. 2012;308:502–11.CrossRef
Metadaten
Titel
Presence of urinary symptoms in bacteremic urinary tract infection: a retrospective cohort study of Escherichia coli bacteremia
verfasst von
Anthony D. Bai
Michael J. Bonares
Samuel Thrall
Chaim M. Bell
Andrew M. Morris
Publikationsdatum
01.12.2020
Verlag
BioMed Central
Erschienen in
BMC Infectious Diseases / Ausgabe 1/2020
Elektronische ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-020-05499-1

Weitere Artikel der Ausgabe 1/2020

BMC Infectious Diseases 1/2020 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.